Fatigue is the most important symptom for advanced cancer patients who have had chemotherapy.
作者： Zeeshan Butt , Sarah K. Rosenbloom , Amy P. Abernethy , Jennifer L. Beaumont , Diane Paul
关键词: Malaise 、 Prostate cancer 、 Head and neck cancer 、 Disease 、 Physical therapy 、 Lung cancer 、 Medicine 、 Cancer Fatigue 、 Internal medicine 、 Quality of life 、 Cancer
摘要: … symptom targets when treating advanced cancer? A survey of providers in the National Comprehensive Cancer … indices to evaluate response to chemotherapy for advanced cancer: …
flinders.edu.au
sci-hub.st 参考文章(10)
L. S. Jones, S. Beck, B. St Pierre, S. Pickard-Holley, M. B. Burke, B. Cimprich, L. M. Nail, M. L. Winningham, L. Brophy, V. Rhodes, Fatigue and the cancer experience: the state of the knowledge. Oncology Nursing Forum. ,vol. 21, pp. 23- 36 ,(1994)
Breitbart W, Cella D, Scherr Sl, Horning Sj, Vogelzang Nj, Portenoy Rk, Itri Lm, Groopman Je, Curt Ga, Johnson Dh, Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Seminars in Hematology. ,vol. 34, pp. 4- 12 ,(1997)
Diane Irvine, Leslie Vincent, Jane E. Graydon, Natalie Bubela, Leslee Thompson, The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy. A comparison with the fatigue experienced by healthy individuals. Cancer Nursing. ,vol. 17, pp. 367- 378 ,(1994) , 10.1097/00002820-199410000-00001
L I Wagner, D Cella, Fatigue and cancer: causes, prevalence and treatment approaches British Journal of Cancer. ,vol. 91, pp. 822- 828 ,(2004) , 10.1038/SJ.BJC.6602012
G. Prue, J. Rankin, J. Allen, J. Gracey, F. Cramp, Cancer-related fatigue: A critical appraisal European Journal of Cancer. ,vol. 42, pp. 846- 863 ,(2006) , 10.1016/J.EJCA.2005.11.026
Zeeshan Butt, Lynne I. Wagner, Jennifer L. Beaumont, Judith A. Paice, Joshua L. Straus, Amy H. Peterman, George Carro, Jamie H. Von Roenn, Dan Shevrin, David Cella, Longitudinal screening and management of fatigue, pain, and emotional distress associated with cancer therapy. Supportive Care in Cancer. ,vol. 16, pp. 151- 159 ,(2008) , 10.1007/S00520-007-0291-2
Martin M. Oken, Richard H. Creech, Douglass C. Tormey, John Horton, Thomas E. Davis, Eleanor T. McFadden, Paul P. Carbone, Toxicity and response criteria of the Eastern Cooperative Oncology Group American Journal of Clinical Oncology. ,vol. 5, pp. 649- 655 ,(1982) , 10.1097/00000421-198212000-00014
D F Cella, D S Tulsky, G Gray, B Sarafian, E Linn, A Bonomi, M Silberman, S B Yellen, P Winicour, J Brannon, The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. Journal of Clinical Oncology. ,vol. 11, pp. 570- 579 ,(1993) , 10.1200/JCO.1993.11.3.570
David Cella, Diane Paul, Susan Yount, Rodger Winn, Chih-Hung Chang, Donald Banik, Jane Weeks, What are the most important symptom targets when treating advanced cancer? A survey of providers in the National Comprehensive Cancer Network (NCCN). Cancer Investigation. ,vol. 21, pp. 526- 535 ,(2003) , 10.1081/CNV-120022366
Jamie H. Von Roenn, Judith A. Paice, Control of common, non-pain cancer symptoms Seminars in Oncology. ,vol. 32, pp. 200- 210 ,(2005) , 10.1053/J.SEMINONCOL.2004.11.019